RESULTS ROUND-UP: Cyberonics boost; HeartWare still making loss; Lombard keeps building in US
This article was originally published in Clinica
Executive Summary
Neuromodulation specialist Cyberonics, which has just agreed to merge with Sorin, got a further boost by seeing its top and bottom lines both expand during its third fiscal quarter. The company’s sales increased 6% to $72.1m, while net income grew to $16.5m, from $13.9m during the same period last year.